Cite
King RS, Peacock-Chambers E, Wilson D, et al. Impact of maternal medication for opioid use disorder on neurodevelopmental outcomes of infants treated for neonatal opioid withdrawal syndrome. J Neonatal Perinatal Med. 2021;14(4):463-473doi: 10.3233/NPM-200615.
King, R. S., Peacock-Chambers, E., Wilson, D., Shimer, J., Foss, S., Visintainer, P., & Singh, R. (2021). Impact of maternal medication for opioid use disorder on neurodevelopmental outcomes of infants treated for neonatal opioid withdrawal syndrome. Journal of neonatal-perinatal medicine, 14(4), 463-473. https://doi.org/10.3233/NPM-200615
King, R S, et al. "Impact of maternal medication for opioid use disorder on neurodevelopmental outcomes of infants treated for neonatal opioid withdrawal syndrome." Journal of neonatal-perinatal medicine vol. 14,4 (2021): 463-473. doi: https://doi.org/10.3233/NPM-200615
King RS, Peacock-Chambers E, Wilson D, Shimer J, Foss S, Visintainer P, Singh R. Impact of maternal medication for opioid use disorder on neurodevelopmental outcomes of infants treated for neonatal opioid withdrawal syndrome. J Neonatal Perinatal Med. 2021;14(4):463-473. doi: 10.3233/NPM-200615. PMID: 33843701.
Copy
Download .nbib